Health aspects of probiotics

IDrugs

Volumn 6, Issue 6, 2003, Pages 573-580

  Ouwehand, Arthur ^a   Vesterlund, Satu ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Bifidobacterium; Intestinal microbiota; Lactobacillus; Prebiotics; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; CHOLESTEROL; LACTOSE; PREBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ALLERGY; BACTERIAL STRAIN; BIFIDOBACTERIUM; BLADDER CANCER; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; DIET; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESEARCH; DRUG SAFETY; ENTERITIS; ENTEROCOCCUS; HEALTH; HUMAN; IMMUNOMODULATION; INTESTINE FLORA; LACTOBACILLUS; LACTOSE INTOLERANCE; MICROORGANISM; NONHUMAN; QUALITY OF LIFE; REVIEW; ROTAVIRUS; URINARY TRACT INFECTION;

ADJUVANTS, IMMUNOLOGIC; DIGESTIVE SYSTEM; FEMALE UROGENITAL DISEASES; GASTROINTESTINAL DISEASES; HUMANS; LACTOSE INTOLERANCE; MALE UROGENITAL DISEASES; PROBIOTICS;

EID: 0038355056     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Moore WE, Holdeman LV: Human fecal flora: The normal flora of 20 Japanese-Hawaiians. Appl Microbiol (1974) 27(5):961-979.
2. Tannock GW (Ed): Normal Microflora. An Introduction to Microbes Inhabiting the Human Body. Chapman & Hall, London, UK (1995).
3. Sanford PA: Digestive system physiology. In: Physiological Principles in Medicine - Second Edition. Hobsley M, Saunders KB, Fitzsimons JT (eds), Edward Arnold, London, UK (1992).
4. Tannock GW: Molecular assessment of intestinal microflora. Am J Clin Nutr (2001) 73(2 Suppl):410S-414S.
5. Brouns F, Kettlitz B, Arrioni E: Resistant starch and "the butyrate revolution". Trends Food Sci Technol (2002) 13(8):251-261.
6. Hopper LV, Midtvedt T, Gordon JL: How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr (2002) 22(1):283-307.
7. Mykkänen H, Laiho K, Salminen S: Variations in faecal bacterial enzyme activities and associations with bowel function and diet in elderly subjects. J Applied Microbiology (1998) 85 (1):37-41.
8. Baba E, Nagaishi S, Fukata T, Arakawa A: The role of intestinal microflora on the prevention of Salmonella colonization in gnotobiotic chickens. Poult Sci (1991) 70(9):1902-1907.
9. Adlerberth I, Cerquetti M, Poilane I, Wold A, Collignon A: Mechanisms of colonisation and colonisation resistance of the digestive tract. Microbial Ecol Health Disease (2000) 12(Suppl 2):223-239. Provides an in-dept overview of the mechanisms behind colonization resistance.
10. Salminen S, Ouwehand A, Benno Y, Lee YK: Probiotics: How should they be defined? Trends Food Sci Technol (1999) 10(3):107-110. Discusses the changing views of what probiotics are.
11. Guarner F, Schaafsma GJ: Probiotics. Int J Food Microbiol (1998) 39(3):237-238.
12. Donnet-Hughes A, Rochat F, Serrant P, Aeschlimann JM, Schiffrin EJ: Modulation of nonspecific mechanisms of defence by lactic acid bacteria: Effective dose. J Dairy Sci (1999) 82(5):863-869.
13. Ouwehand AC, Kirjavainen PV, Shortt C, Salminen S: Probiotics: Mechanisms and established effects. Int Dairy J (1999) 9(1):43-52.
14. Simmering R, Blaut M: Pro- and prebiotics - The tasty guardian angels? Appl Microbiol Biotechnol (2001) 55(1):19-28.
15. Shortt C: The probiotic century: Historical and current perspectives. Trends Food Sci Technol (1999) 10(12):411-417.
16. Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS: Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol (2002) 68(8):3841-3847.
17. McFarland LV, Bernasconi P: Saccharomyces boulardii: A review of an innovative biotherapeutic agent. Microbial Ecol Health Disease (1993) 6(3):157-171.
18. Gibson GR, Roberfroid MB: Dietary modulation of the human colonic microbiotia: Introducing the concept of prebiotics. J Nutr (1995) 125(6):1401-1412. A classic paper that discusses prebiotiocs and their effects on health.
19. Rastall RA, Maitin V: Prebiotics and synbiotics: Towards and next generation. Curr Opin Biotechnol (2002) 13(5):490-496.
20. Roberfroid MB: Prebiotics and probiotics: Are they functional foods? Am J Clin Nutr (2000) 71(6 Suppl):1682S-1687S.
21. Dewit O, Pochart P, Desjeux JF: Breath hydrogen concentration and plasma glucose, insulin and free fatty acid levels after lactose, milk, fresh or heated yogurt ingestion by healthy young adults with or without lactose malabsorption. Nutrition (1988) 4(2):131-135.
22. Kolars JC, Levitt MD, Aouji M, Savaiano DA: Yogurt - An autodigesting source of lactose. N Engl J Med (1984) 310(1):1-3.
23. Savaiano DA, AbouElAnoaur A, Smith DE, Levitt MD: Lactose malabsorption from yogurt, pasteurized yogurt, sweet acidophilus milk, and cultured milk in lactase-deficient individuals. Am J Clin Nutr (1984) 40(6):1219-1223.
24. Martini MC, Smith DE, Savaiano D: Lactose digestion from flavoured and frozen yogurts, ice milk, and ice cream by lactase-deficient persons. Am J Clin Nutr (1987) 46(4):636-640.
25. McDonough FE, Hitchins AD, Wong NP, Wells P, Bodwell CE: Modification of sweet acidophilus milk to improve utilization by lactose-intolerant persons. Am J Clin Nutr (1987) 45(3):570-574.
26. Varela-Moreiras G, Antoine JM, Ruiz-Roso B, Varela G: Effects of yogurt and fermented-then-pasteurized milk on lactose absorption in an institutionalized elderly group. J Am Coll Nutr (1992) 11(2):168-171.
27. Marteau P, Flourie B, Pochart P, Chastang C, Desjeux JF, Rambaud JC: Effect of the microbial lactase (EC 3.2.1.23) activity in yoghurt on the intestinal absorption of lactose: An in vivo study in lactase-deficient humans. Br J Nutr (1990) 64(1):71-79. Analysis of the factors that contribute to the toleration of yogurt by lactose-maldigesting individuals.
28. Lerebours E, N'Djitoyap Ndam C, Lavoine A, Hellot MF, Antoine JM, Colin R: Yogurt and fermented-then-pasteurized milk: Effects of short-term and long-term ingestion on lactose absorption and mucosal lactase activity in lactase-deficient subjects. Am J Clin Nutr (1989) 49(5):823-827.
29. Brandtzaeg PE: Current understanding of gastrointestinal immunoregulation and its relation to food allergy. Ann NY Acad Sci (2002) 964: 13-45. An extensive overview of the gastrointestinal immune system and its role in the development of food allergy.
30. Guarner F, Malagelada JR: Gut flora in health and disease. Lancet (2003) 361(9356):512-519.
31. Blum S, Haller D, Pfeifer A, Schiffrin EJ: Probiotics and immune response. Clin Rev Allergy Immunol (2002) 22(3):287-309. Provides an overview of the role probiotics play in the regulation of the immune system and the proposed mechanisms behind this.
32. Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM: Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol (1994) 10(1):55-63.
33. Spanhaak S, Havenaar R, Schaafsma G: The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr (1998) 52(12):899-907.
34. Strachan DP: Hay fever, hygiene, and household size. Br Med J (1989) 299(6710):1259-1260. A classic paper which discusses the basis for what is known as the 'hygiene hypothesis'.
35. Bach JF: The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med (2002) 347(12):911-920.
36. Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M: Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol (2001) 108(4):516-520.
37. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E: Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol (2001) 107(1):129-134. Intestinal microbiota composition appears to be an early indicator for allergy risk.
38. Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S: Probiotics in the management of atopic eczema. Clin Exp Allergy (2000) 30(11):1604-1610.
39. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E: Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet (2001) 357(9262):1076-1079. First scienctific proof that probiotics can reduce the risk of the development of allergy by 50%.
40. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH: Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet (1994) 344(8929):1046-1049.
41. Shornikova AV, Casas IA, Mykkänen H, Salo E, Vesikari T: Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J (1997) 16(12):1103-1107.
42. Sugita T, Togawa M: Efficacy of Lactobacillus preparation biolactis powder in children with rotavirus enteritis. Jpn J Pediatr (1994) 47(12):2755-2762.
43. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H: Enhancement of the circulating antibody secreting cell response in human Lactobacillus strain. Pediatr Res (1992) 32(2):141-144.
44. Isolauri E, Kaila M, Arvola T, Majamaa H, Rantala I, Virtanen E, Arvilommi H: Diet during rotavirus anteritis affects jejunal permeability to macromolecules in suckling rats. Pediatr Res (1993) 33(6):548-553.
45. Salminen S, Isolauri E, Salminen E: Clinical uses of probiotics for stabilizing the gut mucosal barrier: Successful strains and future challenges. Antonie Van Leeuwenhoek Int J Gen Mol Microbiol (1996) 70(2-4):347-358.
46. Majamaa H, Isolauri E, Saxelin M, Veskari T: Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr (1995) 20(3):333-338.
47. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, Van Belle G: Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study. Gastroenterology (1989) 96(4):981-988.
48. McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL: Prevention of β-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol (1995) 90(3):439-448.
49. Gotz V, Romankiewicz JA, Moss J, Murray HW: Prophylaxis against ampicillin-associated diarrhea with a Lactobacillus preparation. Am J Hosp Pharm (1979) 36(6):754-757.
50. Wunderlich PF, Braun L, Fumagalli I, D'Apuzzo V, Heim F, Karly M, Lodi R, Politta G, Vonbank F, Zeltner L: Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhea and in the treatment of acute diarrhea. J Int Med Res (1989) 17(4):333-338.
51. Black FT, Andersen PL, Örskov J, Örskov F, Gaarslev K, Laulund S: Prophylactic efficacy of lactobacilli on travelers diarrhea. 1st International Conference on Travel Medicine, Zurich, Switzerland (1988):333-335.
52. Oksanen PJ, Salminen S, Saxelin M, Hämäläinen P, Ihantola-Vormisto A, Muurasniemi-Isoviita L, Nikkari S, Oksanen T, Pörsti I, Salminen E, Vapaatalo H: Prevention of travellers' diarrhoea by Lactobacillus GG. Ann Med (1990) 22(1):53-56.
53. Katelaris PH, Salam I, Farthing MJ: Lactobacilli to prevent travellers diarrhea? N Engl J Med (1995) 333(20):1360-1361.
54. Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M: Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther (1997) 11(5):853-858.
55. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT: Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial. Lancet (1999) 354(9179):635-639.
56. Gupta P, Andrew H, Kirschner BS, Guandalini S: Is Lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr (2000) 31(4):453-457.
57. Potter JD: Nutrition and colorectal cancer. Cancer Causes Control (1996) 7(1):127-146.
58. Benno Y, Mitsuoka T, Kanazawa K: Human faecal flora in health and colon cancer. Suppl Acta Chir Scand (1991) 562:15-23.
59. Goldin BR, Gorbach SL: The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. J Natl Cancer Inst (1976) 57(2):371-375. A classic paper that discusses the interaction between diet and fecal enzyme activity and the subsequent risk for colorectal cancer.
60. Brigidi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D: Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiotia in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol (2001) 152(8):735-741.
61. Wollowski I, Rechkemmer G, Pool-Zobel BL: Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr (2001) 73(2 Suppl):451S-455S.
62. Kampman E, Goldbohm RA, Van Den Brandt PA, Van't Veer P: Fermented dairy products, calcium, and colorectal cancer in the Netherlands cohort study. Cancer Res (1994) 54(12):3186-3190.
63. Aso Y, Akazan H. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol Int (1992) 49(3):125-129.
64. Ohashi Y, Nakai S, Tsukamoto T, Masumori N, Akaza H, Miyanaga N, Kitamura T, Kawabe K, Kotake T, Kuroda M, Naito S et al: Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int (2002) 68(4):273-280. Epidemiological study demonstrating risk reduction for the development of bladder cancer after the regular consumption of probiotics.
65. Mann GV: A factor in yogurt which lowers cholesteremia in man. Atherosclerosis (1977) 26(3):335-340.
66. St-Onge MP, Farnworth ER, Jones PJ: Consumption of fermented and nonfermented dairy products: Effects on cholesterol concentrations and metabolism. Am J Clin Nutr (2000) 71(3):674-681.
67. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B: Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol (2001) 30(1):49-52.
68. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M: Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. Br Med J (2001) 322(7318):1571-1575.
69. Hatakka K, Savilahti E, Pönkä A, Meurman JH, Poussa T, Näse L, Saxelin M, Korpela R: Effect of long term consumption of probiotic milk on infections in children attending day care centres: Double blind, randomised trial. Br Med J (2001) 322(7298):1327-1329.
70. Näse L, Hatakka K, Savilahti E, Saxelin M, Pönkä A, Poussa T, Korpela R, Meurman JH: Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res (2001) 35(6):412-420.
71. Juntunen M, Kirjavainen PV, Ouwehand AC, Salminen SJ, Isolauri E: Gut microflora changes and probiotics in children in day care centers. Biosci Microflora (2003): in press.
72. Saran S, Gopalan S, Krishna TP: Use of fermented foods to combat stunting and failure to thrive. Nutrition (2002) 18(5):393-396.
73. Bernardeau M, Vernoux JP, Gueguen M: Safety and efficacy of probiotic lactobacilli in promoting growth in post-weaning Swiss mice. Int J Food Microbiol (2002) 77(1-2):19-27.
74. Ishibashi N, Yamazaki S: Probiotics and safety. Am J Clin Nutr (2001) 73(2 Suppl):465S-470S.
75. Salminen SJ, Von Wright AJ, Ouwehand AC, Holzapfel WH: Safety assessment of probiotics and starters. In: Fermentation and Food Safety. Adams MR, Nout MJ (Eds), Aspen Publishers Inc, Gaithersburg, MD, USA (2001):239-251.
76. Salminen MK, Tynkkynen S, Rautelin H, Saxelin M, Vaara M, Ruutu P, Sarna S, Valtonen V, Järvinen A: Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis (2002) 35(10):1155-1160.
77. Silvi S, Verdenelli MC, Orpianesi C, Cresci A: EU project Crownalife: Functional foods, gut microflora and healthy aging. Isolation of Lactobacillus and Bifidobacterium strains from faecal samples of elderly subjects for a possible probiotic use in functional foods. J Food Engineer (2003) 56(2-3):195-200.
78. De Vrese M, Schrezenmeir J: Probiotics and non-intestinal infectious diseases. Br J Nutr (2002) 88(Suppl 1):S59-S66.
79. Reid G, Bruce AW: Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis (2001) 183(Suppl 1):S77-S80.
80. Cangemi De Gutierrez R, Santos V, Nader-Macías ME: Protective effect of intranasally inoculated Lactobacillus fermentum against Streptococcus pneumoniae challenge on the mouse respiratory tract. FEMS Immunol Med Microbiol (2001) 31(3):187-195.
81. Ouwehand AC, Batsman A, Salminen S: Probiotics for the skin: A new area of potential application? Lett Appl Microbiol (2003) 36(5):327-332.
82. Steidler L: In situ delivery of cytokines by genetically engineered Lactococcus lactis. Antonie Van Leeuwenhoek Int J Gen Mol Microbiol (2002) 82(1-4):323-331. Genetically modified probiotics as a novel means to treat inflammatory bowel disease by in situ production of anti-inflammatory cytokines.
83. Prasad J, Gill H, Smart J, Gopal PK: Selection and characterisation of Lactobacillus and Bifidobacterium strains for use as probiotics. Int Dairy J (1998) 8(12)993-1002.
84. Ouwehand AC, Salminen SJ: The health effects of viable and non-viable cultured milks. Int Dairy J (1998) 8(9):749-758.
85. Lee YK, Lim CY, Teng WL, Ouwehand AC, Tuomola EM, Salminen S: Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria. Appl Environ Microbiol (2000) 66(9):3692-3697.
86. Tuomola E, Crittenden R, Playne M, Isolauri E, Salminen S: Quality assurance criteria for probiotic bacteria. Am J Clin Nutr (2001) 73(2 Suppl):393S-398S.
87. Svensson U: Industrial perspectives. In: Probiotics: A Critical Review. (1999):57-64.